News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 3058
- Sources here
- 17
- Companies here
- 27
Active search
3058 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Entolimod Could Receive Its First National Registration in Ukraine
Valion Bio (Nasdaq: VBIO) announced that Ukraine's Ministry of Health has accepted the regulatory dossier for its ARS countermeasure, Entolimod, for formal review. A favorable decision, which could come as early as Q4 2026, would mark Entolimod's first national registration and could lead to …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banc of California, Inc. - BANC
Pomerantz LLP is investigating Banc of California, Inc. (NYSE: BANC) on behalf of investors following a significant stock price drop. The investigation follows the company's Q2 2026 earnings report, which revealed a net loss of $251.3 million, or $1.61 per share, falling short of …
CWT (NYSE: CWT) trust plans sale of 3,700 shares after prior stock sale
The Thomas & Susan Krummel Family Trust, a shareholder of CWT, has filed a Form 144 to sell 3,700 shares of common stock through Charles Schwab, with an aggregate market value of $184,926.00. These shares were acquired via restricted stock vesting on November 19, …
Ashford Hospitality Trust reports Q2 results
* Ashford Hospitality Trust press release [https://seekingalpha.com/filing/309942820] (AHT [https://seekingalpha.com/symbol/AHT]): Q2 AFFO of $2.67. * Comparable RevPAR for all hotels increased 6.6% to $155.7 during the quarter on a 5.8% increase in Comparable ADR and a 0.7% increase in Comparable Occupancy. * Revenue of $273.24M …
Palisade Bio (PALI): Soleus group reports 7.5% stake, 13.1M shares held
Soleus Capital Master Fund, L.P. and its affiliated entities have filed an amended Schedule 13G, reporting a collective beneficial ownership of 13,063,687 shares of Palisade Bio, Inc. (PALI) common stock. This represents a 7.5% stake in the company, based on 174,270,558 shares outstanding as …
Creative Realities posts Q2 revenue $21.5M, Adjusted EBITDA $2.0M; ARR ~$20.5M
Creative Realities (CREX) announced its second-quarter fiscal 2026 results, reporting revenue of $21.5 million and adjusted EBITDA of $2.0 million. The company's annualized recurring revenue (ARR) reached approximately $20.5 million, supported by the acquisition of Cineplex Digital Media and new contracts, including a significant …
Alithya Reports First Quarter Fiscal 2027 Results
Alithya retains Scotiabank as financial advisor in connection with strategic review process Q1-2027 Highlights Revenues decreased 15.4% to $105.1 million, compared to $124.2 million for the same quarter last year. 77.4% of revenues were generated from clients which we had in the same quarter …
Herbalife’s Incoming CFO to Meet Investors in Chicago Aug. 26
Herbalife Ltd. (NYSE: HLF) announced that Scott Schaefer, incoming Chief Financial Officer, will present at the Midwest IDEAS Investor Conference on August 26, 2026, at 3:20 p.m. CT. A live webcast of the presentation will be available, and a replay will be accessible on …
Alibaba (BABA) Stock May Be 37% Undervalued After Qwen Licensing Shift
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Alibaba Group Holding stock has delivered a 49.2% gain over the past three years, yet valuation checks suggest the market price may still sit …
Y Intercept Hong Kong Ltd Takes Position in California Resources Corporation $CRC
Y Intercept Hong Kong Ltd has acquired 76,082 shares of California Resources Corporation (CRC) for approximately $4.02 million, representing a 0.09% stake. This move comes as California Resources reports strong revenue growth but misses EPS estimates and plans to expand its midstream operations with …
Grocery Chain Selects Creative Realities; 800 Stores Anticipated
Creative Realities (NASDAQ: CREX) reported strong Q2 2026 financial results, with revenue increasing to $21.5 million and Adjusted EBITDA rising to $2.0 million. The company announced a significant contract win with a national grocery chain for a retail media network across 800 locations, estimated …
Creative Realities (NASDAQ: CREX) grows Q2 sales to $21.5M but loss widens
Creative Realities (NASDAQ: CREX) reported a significant increase in Q2 2026 sales to $21.5 million, up from $13.0 million a year prior, driven largely by service revenue and the acquisition of Cineplex Digital Media. Despite this top-line growth and an improved Adjusted EBITDA of …
Herbalife to Present and Host 1x1 Investor Meetings at Midwest IDEAS Investor Conference on August 26
LOS ANGELES, August 13, 2026--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced Scott Schaefer, incoming Chief Financial Officer and current SVP of Finance, will present at the Midwest IDEAS Investor Conference on Wednesday, August 26, 2026 …
Valion Bio, Inc. SEC Filing (Aug 13, 2026)
This article reports on Valion Bio, Inc.'s SEC Filing of type EFFECT on August 13, 2026. The filing has a neutral impact and sentiment, indicating that it is a routine notice of effectiveness for an S-1 registration form. The filing concerns Valion Bio, Inc. …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alibaba Group Holding Limited of Class Action Lawsuit and Upcoming Deadlines - BABA
Pomerantz LLP has filed a class action lawsuit against Alibaba Group Holding Limited (NYSE: BABA) on behalf of investors who suffered losses. The lawsuit alleges securities fraud or other unlawful business practices, citing significant stock drops after Alibaba was included on a U.S. Department …
Sei Investments Co. Purchases Shares of 52,235 Denali Therapeutics Inc. $DNLI
Sei Investments Co. has acquired 52,235 shares of Denali Therapeutics Inc. (NASDAQ:DNLI) valued at approximately $1.0 million, contributing to institutional investors' 92.92% ownership of the company. Despite reporting a quarterly loss of $0.68 per share, Denali's revenue exceeded expectations, and analysts maintain a "Moderate …